Sort
46,585 grants matching “heart failure”
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,339,401Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2009 · HL
Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics
$1,338,683Alain Gerald Bertoni · Wake Forest University Health Sciences · R01 · FY2017 · HL
Chronic Kidney Disease in Children (CKiD)
$1,338,229Susan L Furth · Children'S Hosp Of Philadelphia · U01 · FY2025 · DK
Look AHEAD: Action for Health Diabetes
$1,337,727F. Xavier Pi-Sunyer · St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2011 · DK
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
$1,334,454Scott David Solomon · Brigham And Women'S Hospital · U01 · FY2016 · HL
Viruses and Hematopoiesis
$1,332,323Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,331,513Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2013 · HL
Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation
$1,331,252Adrian E Morelli · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Norms and Performance Comparisons for 5 Health indexes
$1,330,897Dennis G. Fryback · University Of Wisconsin-Madison · P01 · FY2007 · AG
Improving Chronic Disease Management with Pieces (ICD-Pieces)
$1,330,393Miguel A Vazquez · Ut Southwestern Medical Center · UH3 · FY2017 · DK
OTHER FUNCTIONS - IMPLANTABLE BATTERYLESS PACEMAKER AND TELEMETRY DEVICE FOR SMA
$1,329,814Sridhar Madala · Indus Instruments · N44 · FY2012 · HL
JACKSON HEART STUDY (JHS)- COMMUNITY ENGAGEMENT CENTER (CEC) - TASK AREA C CORE STUDIES AND CLOSEOUT ACTIVITIES
$1,329,228Victor Sutton · Mississippi State Department Of Health · N01 · FY2023 · HL
Self-regulating continuous-flow total artificial heart
$1,329,074Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Prenatal Diagnosis Of Congenital Anomalies
$1,327,648Roberto Romero · Child Health And Human Development · Z01 · FY2007 · HD
Pre-DETERMINE: Biologic Markers and MRI SCD Cohort Study
$1,327,357Christine M Albert · Brigham And Women'S Hospital · R01 · FY2020 · HL
Pre-DETERMINE: Biologic Markers and MRI SCD Cohort Study
$1,327,357Christine M Albert · Brigham And Women'S Hospital · R01 · FY2019 · HL
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,326,006Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2012 · HL
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,326,006Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2011 · HL
Genetically-engineered Pig Organ Transplantation into Non-human Primates
$1,325,534David Kc Cooper · University Of Alabama At Birmingham · U19 · FY2016 · AI
Nonmyeloablative allogeneic PBSC in globin disorders
$1,322,542John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
The role of PKD proteins in regulating tubular morphology
$1,322,091Gregory Germino · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
HLS Potent, novel inhibitor of fibrinolytic hemorrhage- Phase II
$1,321,017Sun Yong Jeong · Translational Sciences, Inc. · R44 · FY2019 · HL
Cell-free DNA to detect transplant rejection
$1,320,483Sean Agbor-Enoh · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Long Term Follow up of the Lung Transplant Outcomes Group Cohort
$1,320,463Jason D Christie · University Of Pennsylvania · U01 · FY2020 · HL
Remodeling potential of the mitral valve following surgical repair
$1,319,793Michael S Sacks · University Of Texas At Austin · R01 · FY2016 · HL